Global specialty pharmaceutical and medical device company selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide.
Natick, MA, October 11, 2007 – clinivation, Inc. announced today that Allergan, Inc. (NYSE: AGN) has selected clinivation WorldView® Online Regulatory Intelligence web service.
“We are delighted that Allergan has selected clinivation WorldView as their source for comprehensive, authoritative, and up-to-date regulatory intelligence,” remarked Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions. “With information on >99% of the world markets, Allergan will be able to stay current on ever-changing regulations,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global® enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About Allergan, Inc.
With more than 55 years of experience providing high-quality, science-based products, Allergan, Inc., with headquarters in Irvine, California, discovers, develops and commercializes products in the ophthalmology, neurosciences, medical dermatology, medical aesthetics, obesity intervention and other specialty markets that deliver value to its customers, satisfy unmet medical needs, and improve patients’ lives.
Please visit www.allergan.com to learn more.
